ABBREVIATIONS ACoA = anterior communicating artery; CK = creatine kinase; ECG = electrocardiogram; DSA = digital subtraction angiography; ICA = internal carotid artery; ICG = indocyanine green; ICU = intensive care unit; IOM = intraoperative monitoring; MAP = mean arterial pressure; MCA = middle cerebral artery; MEP = motor evoked potential; mRS = modified Rankin Scale; PCoA = posterior communicating artery; RVP = rapid ventricular pacing; SAH = subarachnoid hemorrhage; SSEP = somatosensory evoked potential; TTE = transthoracic echocardiography; UIA = unruptured intracranial aneurysm. OBJECTIVE To date, treatment of complex unruptured intracranial aneurysms (UIAs) remains challenging. Therefore, advanced techniques are required to achieve an optimal result in treating these patients safely. In this study, the safety and efficacy of rapid ventricular pacing (RVP) to facilitate microsurgical clip reconstruction was investigated prospectively in a joined neurosurgery, anesthesiology, and cardiology study. METHODS Patients with complex UIAs were prospectively enrolled. Both the safety and efficacy of RVP were evaluated by recording cardiovascular events and outcomes of patients as well as the amount of aneurysm occlusion after the surgical clip reconstruction procedure. A questionnaire was used to evaluate aneurysm preparation and clip application under RVP. RESULTS Twenty patients (mean age 51.6 years, range 28-66 years) were included in this study. Electrode positioning was easy in 19 (95%) of 20 patients, and removal of electrodes was easily accomplished in all patients (100%). No complications associated with the placement of the pacing electrodes occurred, such as cardiac perforation or cardiac tamponade. RVP was applied in 16 patients. The mean aneurysm size was 11.1 ± 5.5 mm (range 6-30 mm). RVP proved to be a very helpful tool in aneurysm preparation and clip application in 15 (94%) of 16 patients. RVP was used for a mean duration of 60 ± 25 seconds, a mean heart rate of 173 ± 23 bpm (range 150-210 bpm), and a reduction of mean arterial pressure to 35-55 mm Hg. RVP leads to softening of the aneurysm sac facilitating its mobilization, clip application, and closure of the clip blades. In 2 patients, cardiac events were documented that resolved without permanent sequelae in both. In every patient with successful RVP (n = 14) a total or near-total aneurysm occlusion was documented. In the 1 patient in whom the second RVP failed due to pacemaker electrode dislocation, additional temporary clipping was required to secure the aneurysm, but was not as sufficient as RVP. This led to an incomplete clipping of the aneurysm and finally a remnant on postoperative digital subtraction angiography. A pacemaker lead dislocation occurred in 3 (19%) of 16 patients, but intraoperative repositioning requires less than 20 seconds. Outcome was favorable in all patients according to the modified Rankin Scale. CONCLUSIONS To the best of the authors' knowledge this is the first prospective interdisciplinary study of RVP use in patients with UIAs. RVP is an elegant technique that facilitates clip reconstruction in complex UIAs. The safety of the procedure is good. However, because this procedure requires extensive preoperative cardiological workup of the patient and an experienced neurosurgery and neuroanesthesiology team with much cerebrovascular expertise, actually it remains reserved for selected elective cases and highly specialized centers.
C urrently, most aneurysms can be treated by primary clip reconstruction or by endovascular coil embolization (with or without stents), or with newer devices such as flow diverters or a woven endobridge (WEB) device (Sequent Medical). However, morbidity, mortality, and mid-to long-term occlusion rates of the newer endovascular devices have not been as good as expected. 7, 8, 15, 32 With increasing size and complexity of the aneurysm (wide neck, calcifications, incorporation of branching vessels), the rate of fully occluded aneurysms on postoperative digital subtraction angiography (DSA) decreases while the risk of procedure-related morbidity and mortality increases. 10, 34 However, the number of complex and large or giant unruptured intracranial aneurysms (UIAs) is rising and treatment remains challenging to date. Different tools and techniques can be used surgically in complex aneurysms, such as temporary clipping, adenosine-induced flow arrest, suction decompression, or deep hypothermia with cardiac standstill. 4, 12, 14, 43 Finally, bypass techniques and parent artery occlusion could be the last remaining choices. 20, 27, 31 All of these tools and techniques have advantages and disadvantages, which will be discussed later. Recently, a small series and 3 case reports described the successful use of rapid ventricular pacing (RVP) during aneurysm surgery after subarachnoid hemorrhage (SAH). 21, 30, 38, 45 RVP for flow reduction appears to be a reasonable tool for complex cases. 37, 38, 45 In contrast to adenosine, RVP allows one to control the start time, the length of pacing, and the induced flow/pressure reduction under controlled conditions. 36, 38 Furthermore, the brain parenchyma is still perfused. To date, there are only limited data available for this technique. In this prospective interdisciplinary trial, we focused on patient safety, simplicity of use, efficacy of flow reduction, and improvement of clip application. In this paper we present the data for our first 20 patients.
Methods
The study was approved by the local ethics committee of University Hospital Frankfurt. All patients gave their written informed consent to participate in the study. Only patients with a complex, large, or giant aneurysm were screened for possible trial inclusion.
Inclusion criteria for the study were: 1) age ≥ 18 years, 2) complex UIA intended to be treated by microsurgical clip reconstruction, and 3) application of RVP intraoperatively. Because this study was conducted as a pivotal trial, we only included patients with no obvious structural heart disease or conductance abnormalities, obtained by case history, surface electrocardiogram (ECG), treadmill ECG, and transthoracic echocardiography (TTE). This cardiac workup (surface ECG, treadmill ECG, and TTE) takes less than 3 hours. Furthermore, patients were excluded if they had an increased general periprocedural risk as judged by the anesthesiologist.
Preoperative Workup
After interdisciplinary consensus on aneurysm treatment, patients selected to undergo microsurgical clipping were screened to determine whether the use of RVP would be considered to be helpful during surgery due to aneurysm complexity, size, and/or location (Fig. 1) . 23, 28, 46 All patients considered for RVP during surgery were extensively evaluated by a cardiologist (S.F.) prior to the procedure, including a TTE to detect abnormal wall movements, valvular heart disease, or intraventricular thrombi. Furthermore, a stress ECG was performed. One patient was excluded because the treadmill ECG showed ST elevations and the patient required cardiac stents. Before surgery, 2 neuroanesthesiologists (H.M. and U.S.) consulted with the patient and evaluated the periprocedural risk based on the cardiology workup and the general condition of the patient.
Anesthesia Procedure, Probe Placement, and RVP Testing
Patients received preoperative oral premedication (7.5 mg of midazolam). Before anesthesia induction a peripheral intravenous access line and a radial artery catheter for continuously monitoring arterial blood pressure were placed. Anesthesia was induced with sufentanil, propofol, and rocuronium and maintained with continuous application of remifentanil and propofol according to the intraoperative needs. After insertion of a central venous catheter (9.5-Fr diameter, 5 lumens, 20 cm long) for central venous pressure monitoring and drug administration, a vascular introducer sheath with a large infusion port (Arrow Flex FEP Sheath, 6-Fr diameter, 10-cm length) was placed into the subclavian vein. Standard monitoring included pulse oximetry, ECG, invasive blood pressure monitoring, capnography, and esophageal and bladder temperature. A 5-Fr balloon temporary pacing catheter (Arrow, Vascostim) was introduced through the vascular introducer in the subclavian vein into the right ventricle. Correct positioning of the pacing electrode was confirmed via continuous ECG monitoring under pacer stimulation with a low pacing threshold. External defibrillation pads were placed on the chest wall.
Surgical Procedure and Intraoperative Monitoring
Clip placement as well as complex clip reconstruction techniques were performed by the senior author (V.S.) in a standardized microsurgical procedure, opening the sylvian fissure and basal cisterns. All procedures were conducted using intraoperative monitoring (IOM) of somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs). 42 The patients were kept normovolemic with a mean arterial pressure (MAP) of 70-100 mm Hg. Additionally, mild hypothermia (35°C) and burst suppression were induced before aneurysm clipping. A pterional craniotomy was used as the standard approach for all aneurysms. Intraoperatively, indocyanine green (ICG) video angiography was used to verify aneurysm occlusion as well as parent vessel perfusion after each clip placement. 35 Initially, we tried to clip the aneurysm without additional techniques, but if this was not possible, the next step was to use RVP. However, in patients without sufficient flow reduction by RVP, other techniques were allowed, such as temporary clipping or induced hypotension. We differentiated between whether insufficient flow reduction was due to pacemaker dislocation or due to RVP by itself; this could be easily identified by a change of the QRS complex under sufficient RVP (Fig. 2) .
Initially, RVP was started at a rate of 150 bpm and gradually increased to approximately 200 bpm until the effect on blood pressure was registered. The primary goal was to "titrate" the MAP to or below 50 mm Hg, depending on the surgeon's preference (e.g., intraaneurysmal pressure reduction). A pulsatile flow in the arterial wave form was demanded, to maintain a minimum cardiac output during the procedure.
Cardiac and Postoperative Workup
After surgery, all patients were admitted to the neurosurgical intensive care unit (ICU). Cardiac enzymes were controlled preoperatively, at ICU admission and the day after the procedure. All patients were monitored with continuous ECG for 24 hours. On Day 7, aneurysm occlusion was assessed by control DSA. Patient outcome was assessed using the modified Rankin Scale (mRS) during an outpatient visit 6 months after surgery.
Statistical Analysis
The anesthesiologist and performing surgeon were required to complete a questionnaire on perioperative handling, intraoperative effects, aneurysm preparation, and clip application. Data were collected prospectively into an SPSS database (IBM Corp.). An unpaired t-test was used for parametric statistics. Categorical variables were analyzed in contingency tables using the Fisher exact test. Results with a p value ≤ 0.05 were considered statistically significant. All calculations were made with standard commercial software (IBM SPSS).
Trial Registration
This prospective noninterventional study was approved by the local ethics committee of Goethe University Hospital Frankfurt and registered with the ClinicalTrials.gov database (http://clinicaltrials.gov); its registration no. is NCT02766972.
Results
During the 31-month study period, 174 patients with UIAs were treated. Twenty patients (11%) with complex UIAs were included in this trial (Tables 1 and 2) . No aneurysm ruptured during treadmill ECG, TTE, or RVP. The mean age of the patients was 51.6 years (range 28-66 years), and 75% were female.
Application of RVP
Aneurysm preparation and clip application was first attempted without the use of RVP. Intraoperative RVP was not required for safe clip application in 3 patients (15%). In 1 patient (5%), the aneurysm was not treated at all because it was predominantly a fusiform aneurysm and heavily calcified, as detected during intraoperative inspection. Therefore, in 16 (80%) of 20 patients RVP was used intraoperatively. In all patients (100%) the pacemaker electrodes were placed in the anesthesiology preparation room ( Fig. 3 ) and tested for a few seconds. Probe placement and testing required 5-10 minutes. In 1 patient an ultrasound was needed to verify probe placement; thus this patient spent 20 minutes more in the preparation room than a patient without RVP.
Therefore, 24 times RVP was successfully applied in 15 (94%) of 16 patients (Fig. 3 , Table 2 ). Most patients re- , and in another patient, after an initial RVP with excellent effect, the second RVP did not work (Case 18). However, a repositioning is usually easy, and after adopting the internal guidelines and allowing this repositioning in Case 20, the electrodes were corrected and the RVP had an excellent effect (MAP 35 mm Hg).
quired only 1 pacing, but RVP was used up to 4 times in 1 patient (Case 1, Table 2 ). During a mean duration of 60 ± 25 seconds of RVP with a mean heart rate of 173 ± 23 bpm (range 150-210 bpm), a reduction of the MAP (range 35-55 mm Hg) was achieved. This led to a significant reduction of the wall tension of the aneurysm and thus facilitated the preparation of the aneurysm and clip application or parent-vessel clip reconstruction with aneurysm occlusion (Fig. 3 , Table 3 ). In 3 (19%) of 16 patients RVP failed due to pacemaker lead dislocation. In 1 of these patients (Case 14), despite the use of other techniques (induced hypotension and temporary clipping), the complex posterior communicating artery (PCoA) aneurysm (14 mm, neck incorporating PCoA origin and posterior wall of the internal carotid artery [ICA]) could not be clipped safely without the use of RVP so the procedure was terminated without securing the aneurysm. This aneurysm was treated subsequently by placement of a flow diverter because conventional coiling was not possible due to the configuration of the aneurysm. In another patient (Case 18) the first RVP was successful as preparation of both A 2 segments (which were very adherent to the aneurysm sac) was performed easily and clip application was performed. However, ICG showed a significant remnant, so a second RVP was tried but failed due to pacemaker electrode dislocation. Therefore, additional temporary clipping was used instead, but flow reduction was not as sufficient as under RVP. This led to an incomplete clipping of the aneurysm and finally a remnant on postoperative DSA. However, if the pacemaker electrodes were positioned correctly in the preparation room, a repositioning was not that difficult. Thus, we changed our internal guidelines and allowed intraoperative repositioning. In the third patient (Case 20) the first RVP failed due to dislocation of the pacemaker electrode. Repositioning required less than 20 seconds, and the complex middle cerebral artery (MCA) trifurcation aneurysm could be clipped successfully. During RVP, no changes in the intraoperatively measured SSEPs, MEPs, or EEGs were detected.
Aneurysm Characteristics
The mean size of the aneurysms was 11.1 ± 5.5 mm (range 6-30 mm). Seven aneurysms were large (≥ 10 mm) and 1 was giant (30 mm). The majority of aneurysms had a wide neck and/or were dysplastic, and at least 1 origin of the branching vessels was incorporated (Figs. 4-6 ).
In 15 (94%) of 16 patients, RVP was applied intraoperatively to secure the aneurysm. Mean aneurysm size was 11.6 ± 6.2 mm, with 6 aneurysms ≥ 10 mm. The neck was wide in nearly all and calcified in most of these aneurysms, which made clip application more difficult and sometimes prevented the closure of the clip blades. Dislocation of the clip downward to the parent vessel was noted in some of the aneurysms when a first attempt at clipping was performed without using RVP. This was due to calcifications in the region of the neck or the increased tension of the aneurysm wall. In 1 of these aneurysms, an endovascular approach was aborted without success prior to clip placement (Case 12). In most of the aneurysms the branching vessels were at least partly incorporated at the origin of the aneurysm. Two aneurysms originated at the paraclinoid ICA, where intradural proximal control is difficult to achieve and visualization of the clip blades during closure is limited.
Cardiovascular Events
In most patients, no cardiovascular events were recorded during or after the procedure. The serum levels of cardiovascular markers (troponin T, creatine kinase [CK], and CK-MB) were within normal range or slightly elevated. However, the levels of patients with RVP were lower than the levels without use of RVP intraoperatively (Table 3) .
In 1 (6%) of the 16 patients (Case 3) electrical cardioversion was applied after the second episode of RVP intraoperatively due to supraventricular tachycardia. The fourth patient who underwent RVP intraoperatively (Case 5) developed a pulseless electrical activity with ventricular fibrillation after RVP due to extensive stimulation (120 seconds) requiring approximately 50 chest compressions before spontaneous recovery. Both patients made a full recovery. No other arrhythmias or ischemic abnormalities were documented during 24 hours of continuous ECG monitoring after the procedure. However, after adopting our internal guidelines (RVP autonomously stopped by the anesthesiologist after 100 seconds), no further pulseless electrical activity with ventricular fibrillation occurred.
No complications associated with placement of the pacing electrodes occurred, such as cardiac perforation or cardiac tamponade. One patient (Case 8) suffered from myocardial infarction 10 months after the procedure. RVP was not applied intraoperatively in this patient and the preoperative diagnostics did not display any abnormalities. 
Outcome
Outcome 6 months after aneurysm occlusion was favorable in all patients (n = 19; mRS score 0-2). Only 1 patient had an mRS score of 2 (pre-and postoperatively), but this was related to a previous SAH from a different aneurysm. One patient (treated in March 2016) had an mRS score of 1 at discharge.
Discussion
The treatment of complex and large UIAs remains challenging to date. Complete circumferential exposure of the aneurysm, branches, and perforators is required prior to safe and effective clip application. Yet, aneurysm dissection and visualization of major branches or perforators incorporated into the aneurysm base can be very demanding. Despite the development of various supplementary techniques to facilitate neurosurgical clip reconstruction in the past, such as induced hypotension, suction decompression, temporary clipping, transient cardiac standstill, or bypass surgery, every method still has its specific drawbacks. Also, the application of advanced techniques, which usually carry an additional risk for the patient, has to be weighed against the significant risk of intraoperative aneurysm rupture in these complex aneurysms.
In this study, we prospectively assessed the safety and efficacy of RVP in microsurgical clip reconstruction of complex UIAs in an interdisciplinary setting. We found that RVP is a very efficient technique that facilitates clip reconstruction with a low risk for the patient. RVP works mainly by softening of the aneurysm sac, even in very large or complex aneurysms as well as in calcified aneurysms, which then significantly improves the aneurysm mobilization and allows better visualization of the aneurysm's neck and branching vessels.
RVP decreases cardiac output and MAP by reducing the stroke volume by desynchronization of the atrial and ventricular action, ventricular dyskinesis, and a shorter diastolic filling time. 44 Onset and duration can be individually adapted to the needs of the intervention. 9, 44 After its first description in neurosurgery in the 1960s, this technique was abandoned in the 1970s and almost forgotten until 1 small series and 3 case reports reported its successful use in cerebrovascular surgery. 21, 30, 38, 45 
Patient Safety
In this series, two cardiovascular events were noted in relation to RVP: 1 patient suffered from ventricular fibrillation while another developed atrial fibrillation, which both resolved after adequate intraoperative measures without sequelae. We suspect that some degree of hypovolemia leading to a reduction of myocardial perfusion during RVP might have contributed to the development of ventricular fibrillation in the affected patient. Second, the heart rate used for RVP might have been too high in this patient. After changing our guidelines with a focus on avoidance of hypovolemia and a stepwise increase of the pacing velocity until a sufficient effect was noted, we did not observe a similar event.
Both events are known complications of RVP, which are reported to be between 0% and 3%. Tachyarrhythmias are the most common complications, which are usually reversed with defibrillation or cardioversion. 21, 44 This risk is highest in patients with aortic stenosis, severe left ventricular dysfunction, or coronary heart disease, which therefore have to be excluded before starting RVP. 11, 44 Therefore, it appears reasonable to limit the frequency and duration of RVP as much as possible and to ensure adequate recovery of left ventricular systolic function and MAP prior to further pacing. 44 Interestingly, patients who underwent RVP did not have the highest levels of heart enzymes postoperatively, and no signs of cardiac infarctions. A neurological deficit did not occur. Interestingly, in patients with successful clip placement with RVP, the levels were lower than in patients with non-RVP clipping.
A fundamental rule in our experience is that the anesthesiologist has to monitor the duration of RVP application and inform the surgeon at 30-, 60-, and 90-second time periods so that RVP can be terminated after 100 seconds. The MAP should not regularly be below 40 mm Hg.
No other arrhythmias or ischemic abnormalities were documented during 24 hours of continuous ECG monitoring after the procedure. However, after adopting our internal guidelines (focus on avoidance of hypovolemia and a stepwise increase of the pacing velocity; RVP terminated after 100 seconds), no further pulseless electrical activity or arrhythmias occurred. No complications associated with placement of the pacing electrodes occurred, such as cardiac perforation or cardiac tamponade (Fig. 3) .
One of the major benefits of RVP, especially compared with temporary clipping, is the residual flow (of heart, body, and brain) resulting in constant and slow cerebral perfusion. In contrast to temporary clipping, the IOM identified no alterations of EEGs, SSEPs, or MEPs, which is supported by the data of Argiriadou et al., who showed that RVP did not affect cerebral oxygenation. 2 The outcome of the patients in the present series was excellent, especially considering the complexity of the treated aneurysms.
Simplicity of RVP
After discussion of the procedure by our ethics board, we had to use high standards to include the patient participants. Nonetheless, an exercise-based ECG and TTE are currently standard procedures. The implantation of the catheter was performed by an anesthesiologist. The survey showed that a transesophageal echocardiogram was required for preoperative implantation into the right ventricle in only 1 patient (5%; Fig. 3 ). However, in 3 (19%) of 16 patients a dislocation occurred. In 2 patients prior to and in 1 patient after the first use of RVP, electrode dislocation occurred. After changing the internal guidelines (and allowing repositioning after skin incision), in 1 patient (Case 20) the catheter was repositioned very easily (1-2 mm inside) and fast (less than 20 seconds). Therefore, we documented a translocation of the pacemaker lead in 15%. RVP is an elegant technique, and (as requested by the surgeon) the anesthesiologist has a device with on/off demand for a tailored induction of hypotension (i.e., heart rate increase) with residual cerebral and heart perfusion.
Efficacy of Flow Reduction and Improvement of Clip Application
In every patient with successful RVP (n = 15) the operating surgeon (V.S.) rated the efficacy of flow arrest as excellent (100%; Fig. 3 ). However, in 1 (6%) of 16 patients RVP failed due to lead dislocation. One of the most important advantages is the control of RVP, specifically flow reduction. After visualization of the aneurysm, the surgeon gives a command to be prepared for clip application or dissection of perforators, and the anesthesiologist begins RVP. Seconds later the aneurysm becomes slack and soft. Subsequently, clip application is much easier because of the reduced flow (Video 1). Most often, RVP was used directly for the application of the clips, which allowed better control and visualization of the closure of the blades. The aneurysm sac became significantly softer by reduced wall tension during RVP in all cases (100%), which facilitated its mobilization and manipulation. Thus, dissection of adhering vessels to the aneurysm neck, and circumferential visualization of the neck and the branching or perforating vessels, was improved.
Why RVP and Not Adenosine?
The complication rate after RVP, which has to be weighed against the considerable risk of spontaneous rupture of the aneurysms treated in this series, appears to be comparable to or lower than that reported after administration of adenosine in retrospective studies (Table 4) . 4, 5, 22 Adenosine is easy available and usable, but it is not predictable, if the cardiac arrest persists (up to 20% of the patients had no effect in a prospective trial 11 ) and depending on how long (most often 10-30 seconds); 3, 5, 18, 25 with RVP the anesthesiologist has a device with on/off demand for a tailored induction of hypotension. Also, after adenosine application, hypotension persists longer (5-10 minutes) than after RVP, requiring vasoactive agents in some patients. 1, 18, 26 RVP data exist showing that cerebral oxygenation is not affected, 2 whereas induced hypotension by adenosine, nitroglycerin, nitroprusside, isoflurane, or others should be as short as possible, as we know from studies that it is associated with reduction of cerebral oxygenation and associated with permanent deficits and stroke depending on duration and extent of hypotension. 16, 19, 24, 33, 40, 47 In contrast to RVP vasoactive agents, sometimes several are required after adenosine or induced hypotension.
However, the cardiac risks of adenosine and RVP are similar (arrhythmias), and elective patients should have the same preoperative cardiac checkup, especially in a prospective trial. Finally, adenosine has a high side-effect profile, whereas RVP is established from transcatheter aortic valve implantation and is very safe. 9, 11, 44 In contrast to adenosine, RVP cannot be administrated spontaneously in the case of intraoperative aneurysmal rupture 4 as the pacemaker electrode needs to be in place beforehand. However, if the electrode was placed in the preparation room, RVP can be used in patients with SAH as well as during rupture to control bleeding. 38 In addition, a preoperative cardiac workup is highly recommended. During screening 1 patient was excluded because the treadmill ECG showed ST elevations and the patient required cardiac stents.
However, with adenosine, atrial fibrillation was reported in 5%-9%, elevated troponin levels without evidence of cardiac dysfunction in 8%-12%, transient arrhythmias occurred in 8%-13%, closed chest compressions due to prolonged hypotension were required in 4%, and postoperative neurological deficits occurred in as many as 12.5% in a retrospective trial. 3, 4, 18, 25 Despite the required chest compression (6%), in our prospective series RVP had better values than using adenosine (Table 4 ). However, we used adenosine earlier and changed to RVP. We prefer RVP, especially due to the good control of flow reduction (by time and effect) in contrast to the unpredictable adenosine and the requirement of vasoactive agents. Additionally, in these complex UIAs with clip reconstruction, the majority of RVP procedures required a duration of ≥ 40 seconds (Figs. 4 and 5), which is typically not possible with adenosine. Nonetheless, both techniques are eligible for aneurysm surgery, and data comparing both techniques are still missing.
Why RVP and Not Temporary Clip Placement or Revascularization?
Compared with temporary clip placement, which also leads to a reduction of aneurysm wall tension, there is residual perfusion in the dependent vessel territory under RVP. In contrast to temporary clipping, where several minutes of flow arrest are usually achieved, the duration achieved by RVP is shorter. 17 Also in contrast to temporary clipping, the IOM identified no alterations of EEGs, SSEPs, and MEPs, and cerebral oxygenation was also not affected. 2 Additionally, temporary clipping is associated with the risk of vessel wall injury or thromboembolic complications. 5, 13 Especially in the presence of vessel-wall sclerosis or a prolonged temporary clipping interval, postoperative ischemic deficits may occur. 17 Sometimes the temporary clip itself might limit the application of the permanent clip, especially in narrow surgical corridors. 29 For paraclinoid aneurysms (Fig. 6) we used carotid artery occlusion, but similar to intracranial temporary clipping of the carotid artery, in the cervical ICA thrombosis can also occur. 5 However, we also used additional temporary clipping in some cases. As mentioned previously, in 1 patient the first RVP was successful and preparation of both A 2 segments (which were very adherent to the aneurysm sac) was relatively easily, whereas temporary clipping was not as sufficient as RVP. Therefore, temporary clipping is an adequate technique but, depending on collateral circulation, sometimes not as effective for general blood flow reduction due to RVP.
We believe that clip reconstruction of the aneurysm and preservation of the patient's vasculature is superior to any revascularization procedure. We therefore spare no effort to achieve this goal. In contrast to RVP (Table  4) , revascularization procedures showed higher risks of periprocedural ischemia (up to 29%) 6 for complex cerebral aneurysms, which is often associated with a significant morbidity rate. 41 However, with RVP or adenosine a few aneurysms cannot be reconstructed, and for these cases revascularization techniques may be an alternative.
Limitations of the Study
Besides the limited number of patients, which is related to the complex nature of the aneurysms selected for RVP application at our institution, there are other limitations to this study. We did not compare the safety and efficacy of RVP to other methods of transient cardiac standstill such as adenosine injection. Furthermore, there is no control group included in this series, but this can hardly be achieved due to the complexity of each individual aneurysm.
At present, after we have used RVP successfully in 15 of 20 patients more than 20 times, and after adjusting the guidelines, we feel confident that we have identified a safe corridor for RVP use: 1) after insertion of electrode, test RVP (with a starting heart rate of 150 bpm) to find a heart rate for a MAP of approximately 50 mm Hg; 2) intraoperatively reposition the pacemaker lead if it dislocates; and 3) monitor the duration of RVP application by an anesthesiologist and inform the surgeon at 30-, 60-, and 90-second time periods. RVP should be terminated after 100 seconds during 1 pacing.
Conclusions
RVP is an elegant technique that significantly improves clip reconstruction in complex UIAs. The safety of the procedure is good. Yet, because this technique requires extensive preoperative cardiological workup of the patient and an experienced neurosurgical and neuroanesthesiology team with much cerebrovascular expertise, actually it remains reserved for selected elective cases and highly specialized centers. After having accumulated experience with RVP we believe it should be further evaluated in a multicenter trial.
